Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies

Go back to Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
(NASDAQ: QNRX) Delayed: 3.90 -0.13 (3.23%)
Previous Close $4.03    52 Week High $ 
Open $4.00    52 Week Low $ 
Day High $4.11    P/E N/A 
Day Low $3.90    EPS $ 
Volume 31,741       

Skinvisible, Inc. (AMEX: SKVI) Delayed: 0.16 -0.04 (20%)
Previous Close $0.20    52 Week High $0.04 
Open $0.16    52 Week Low $0.00 
Day High $0.16    P/E N/A 
Day Low $0.16    EPS $-0.01 
Volume 905